ConductScience.org, home

Paper19476397

Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis.

Díaz-Borjón A. Drugs Aging, 2009. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis. Papers, record 19476397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19476397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis.
PubMed
Journal
Drugs Aging
PubMed
Year
2009
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2021-10-20
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Díaz-Borjón AAlejandro

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antirheumatic AgentsMajor topic
Arthritis, RheumatoidMajor topic
Immunologic FactorsMajor topic
Aged
Aging
Humans
Practice Guidelines as Topic

Source PubMed

Download CSV of topics

References179

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116258899Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.Arthritis Rheum2005https://conductscience.org/library/papers/16258899PubMed
214616975High prevalences of vitamin B12 and folic acid deficiency in elderly subjects in Israel.Br J Haematol2003https://conductscience.org/library/papers/14616975PubMed
315552522Benefit/risk of cyclosporine in rheumatoid arthritis.Clin Exp Rheumatol2004https://conductscience.org/library/papers/15552522PubMed
46881184Hydroxychloroquine in the treatment of rheumatoid arthritis.Am J Med1983https://conductscience.org/library/papers/6881184PubMed
517655372Clinical pharmacokinetics and use of infliximab.Clin Pharmacokinet2007https://conductscience.org/library/papers/17655372PubMed
61977391The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses.Arthritis Rheum1990https://conductscience.org/library/papers/1977391PubMed
89929017Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.Lancet1999https://conductscience.org/library/papers/9929017PubMed
915264435Technology evaluation: abatacept, Bristol-Myers Squibb.Curr Opin Mol Ther2004https://conductscience.org/library/papers/15264435PubMed
102112243Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.Pharmacotherapy1990https://conductscience.org/library/papers/2112243PubMed
111920331The effect of age on methotrexate efficacy and toxicity.J Rheumatol1991https://conductscience.org/library/papers/1920331PubMed
1215082480Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed.Ann Rheum Dis2004https://conductscience.org/library/papers/15082480PubMed
134037555Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.Ann Intern Med1985https://conductscience.org/library/papers/4037555PubMed
1414963199Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.Rheumatology (Oxford)2004https://conductscience.org/library/papers/14963199PubMed
156869410Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials.Am J Med1983https://conductscience.org/library/papers/6869410PubMed
166813481The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.J Rheumatol Suppl1982https://conductscience.org/library/papers/6813481PubMed
173883172Efficacy of low-dose methotrexate in rheumatoid arthritis.N Engl J Med1985https://conductscience.org/library/papers/3883172PubMed
181747702Should disease-modifying agents be used in mild rheumatoid arthritis?Br J Rheumatol1991https://conductscience.org/library/papers/1747702PubMed
1911034720Azathioprine for treating rheumatoid arthritis.Cochrane Database Syst Rev2000https://conductscience.org/library/papers/11034720PubMed
202896459Sulfasalazine: II. Some notes on the discovery and development of salazopyrin.Am J Gastroenterol1988https://conductscience.org/library/papers/2896459PubMed
217352462The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.Am J Epidemiol1980https://conductscience.org/library/papers/7352462PubMed

See all 179 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
39914430Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG).Lancet Oncol2025https://conductscience.org/library/papers/39914430PubMed
39712845Clinical Characteristics of Young-Onset Versus Elderly-Onset Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.Cureus2024https://conductscience.org/library/papers/39712845PubMed
39583861How Were the Elderly RA Patients Doing Over the Past Year?-A Post Hoc Analysis for Telephone Based Following Up to RA Patients in Zunyi China.J Inflamm Res2024https://conductscience.org/library/papers/39583861PubMed
37856034Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry.Rheumatol Ther2023https://conductscience.org/library/papers/37856034PubMed
36104655Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients.Drugs Aging2022https://conductscience.org/library/papers/36104655PubMed
33205322Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort Study.Drugs Aging2020https://conductscience.org/library/papers/33205322PubMed
33078092Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis.Acta Pharm Sin B2020https://conductscience.org/library/papers/33078092PubMed
28224284Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the Pharmacological Management of Elderly Patients.Drugs Aging2017https://conductscience.org/library/papers/28224284PubMed
26123949Diagnosis and Management of Late-Onset Spondyloarthritis: Implications of Treat-to-Target Recommendations.Drugs Aging2015https://conductscience.org/library/papers/26123949PubMed
24676590[Safety of antirheumatic drug treatment in the elderly].Z Rheumatol2014https://conductscience.org/library/papers/24676590PubMed
24197607Elderly-onset sarcoidosis: prevalence, clinical course, and treatment.Drugs Aging2013https://conductscience.org/library/papers/24197607PubMed
24105334Rheumatoid arthritis in the elderly in the era of tight control.Drugs Aging2013https://conductscience.org/library/papers/24105334PubMed
23509636Clinical and radiological presentations of late-onset spondyloarthritis.ISRN Rheumatol2011https://conductscience.org/library/papers/23509636PubMed
21124693Pattern of Young and Old Onset Rheumatoid Arthritis (YORA and EORA) Among a Group of Egyptian Patients with Rheumatoid Arthritis.Clin Med Insights Arthritis Musculoskelet Disord2010https://conductscience.org/library/papers/21124693PubMed
20583847Late-onset ankylosing spondylitis and spondylarthritis: an update on clinical manifestations, differential diagnosis and pharmacological therapies.Drugs Aging2010https://conductscience.org/library/papers/20583847PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19476397

GET https://conductscience.org/api/papers/v1/19476397/references?page=2